ADDRESSING THE NEED FOR GREATER PUBLIC RETURN ON PUBLIC INVESTMENT

CONTEXT Several initiatives at national, regional and global levels have attempted to correct the Licensing of IP, know-how and other imbalance and improve the inef昀椀ciencies of forms of knowledge and data is one of the public contributions to biomedical R&D. [...] the consequences of unequal distribution of Civil society and academia made substantial innovation and the inability of market forces contributions to the discussion, successfully alone to effectively respond to health needs in pushing for open science tenets and greater emergency settings. [...] Since The mRNA Tech Transfer Hub launched in its inception, C-TAP has secured the rights June 2021 with the support of WHO and the to the research portfolio of the US National MPP among other institutions, and based in Institute of Health (NIH)14 and the licence to a the premises of Afrigen, Cape Town, South diagnostic kit developed by the Consejo Superior Africa. [...] The Health Emergency Preparedness and Response Authority (HERA) was created in In relation to improved access and the December 2021 as part of the EU response distribution of biomedical innovation, the to pandemics and other health emergencies. [...] Mapping of long-term public and private investments in the development of Covid-19 vaccines, publication for the special committee on COVID-19 pandemic: lessons learned and recommendations for the future (COVI), Policy Department for Economic, Scienti昀椀c and Quality of Life Policies, ADDRESSING THE NEED FOR GREATER PUBLIC RETURN ON PUBLIC INVESTMENT 9 HEALTH ACTION INTERNATIONAL European Parliamen.